When the surgery succeeded — and the pain never left.
Ketamine for post-surgical pain in Baltimore is an off-label IV infusion — $1,499.99 per session, $1,125 for Vitality Circle members — evaluated for the central sensitization behind chronic post-surgical pain (CPSP): the NMDA receptor hyperactivity established during the surgical injury that persists after the tissue has healed. Every infusion is anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD — Johns Hopkins Assistant Professor of Anesthesiology and Chief of Thoracic Anesthesia, the surgery with the highest CPSP risk — with a Certified Registered Nurse Anesthetist (CRNA) on-site. Evaluated conditions include phantom limb pain, post-thoracotomy pain syndrome (PTPS), post-mastectomy pain syndrome (PMPS), post-sternotomy pain, and chronic post-hernia-repair pain. Pain persisting beyond 3 months after surgery is the marker that central sensitization has become dominant. Surgical follow-up care continues. Spine post-surgical pain is covered on the Back Pain and Sciatica pages. Ketamine is off-label and results vary. $1,499.99/session non-member · $1,125/session Vitality Circle member.
Mon–Fri: 1PM–8PM · Sat: 10AM–2PM
513 Bayview Blvd, Canton, Baltimore MD 21224
(443) 563-1059
Answer a few quick questions — our clinical team reaches out within 1 business day to discuss whether ketamine therapy may be right for you.
Your information is confidential. A clinical team member follows up within 1 business day.
If you have chronic pain after a surgery that otherwise went well, it does not mean the surgery failed, that something was done wrong, or that there is new damage that needs to be found. In most cases of chronic post-surgical pain, the tissue has healed exactly as it should have. What has not reset is the pain signaling system — the nervous system learned the pain during the surgical injury and continued generating it after the healing was complete. This is a real, defined, well-documented neurological phenomenon called central sensitization. It is not in your head, and it is not permanent by necessity.
Chronic post-surgical pain (CPSP), also called persistent post-surgical pain, is defined as pain that develops after a surgical procedure and persists beyond the normal healing period — conventionally at least 3 months — after other causes (infection, recurrence, hardware problems) have been excluded. It is one of the most common yet least discussed complications of surgery. Patients are frequently discharged from surgical follow-up once the incision has healed and imaging looks normal, then left without a clear explanation for why their pain continues — or a clear path to addressing it.
The reason conventional post-surgical evaluation so often finds nothing is that the pathology is not at the surgical site — it is in the central nervous system. During the surgical injury, intense nociceptive input drives NMDA receptor activation in the spinal cord dorsal horn, establishing central sensitization. In most patients, this resolves as healing completes. In those who develop CPSP, the central sensitization becomes self-sustaining — the nervous system continues generating and amplifying pain signals long after the peripheral injury has healed. This is the mechanism ketamine's NMDA blockade directly targets.
Understanding how CPSP develops explains both why it persists and why an NMDA-targeted therapy is mechanistically appropriate. The transition from acute surgical pain to chronic post-surgical pain follows a defined neurological sequence.
Surgery necessarily involves cutting through skin, muscle, nerves, and other tissue — generating intense, sustained nociceptive signaling to the spinal cord. This is unavoidable in any significant surgical procedure and is normally managed with perioperative anesthesia and analgesia.
The intense nociceptive input drives glutamate release and NMDA receptor activation in the spinal cord dorsal horn — initiating central sensitization. The spinal cord neurons become hyperexcitable, amplifying pain signals. This is a normal, expected response to acute surgical injury.
As the surgical wound heals and nociceptive input decreases, the central sensitization normally resolves. The spinal cord returns to baseline excitability, and pain resolves along with tissue healing. This is what happens for the majority of surgical patients.
In patients who develop chronic post-surgical pain, the central sensitization does not resolve — it becomes self-perpetuating. NMDA receptor hyperactivity continues generating and amplifying pain signals independently of the now-healed surgical site. The pain has become the disease, decoupled from any ongoing tissue damage.
Ketamine's NMDA receptor blockade directly interrupts the hyperactive spinal cord signaling that maintains chronic post-surgical pain. By blocking the NMDA receptors through which central sensitization is sustained, ketamine may reduce the self-perpetuating amplification driving CPSP — targeting the actual mechanism rather than a surgical site that has already healed.
Why this matters for treatment selection: because the pain is maintained centrally rather than by ongoing tissue damage, treatments directed at the surgical site — repeat imaging, revision surgery, local injections — often provide limited benefit for true CPSP. The central sensitization mechanism is what ketamine evaluation addresses.
Pain perceived in a limb that has been amputated — affecting a majority of amputees. Because the limb is gone, there is no peripheral pain generator: phantom limb pain is generated and maintained centrally, through cortical reorganization and NMDA-mediated central sensitization. This makes it the most mechanistically compelling application of ketamine in post-surgical pain. Eichenberger et al. (2008, Anesth Analg) demonstrated in a randomized controlled trial that IV ketamine significantly reduced phantom limb pain.
Chronic pain persisting along the thoracotomy incision and intercostal nerve distribution after chest surgery — one of the most common chronic post-surgical pain syndromes because of near-unavoidable intercostal nerve injury during thoracotomy. Combines a neuropathic component (intercostal nerve damage) with central sensitization. Persistent burning, aching, and hypersensitivity along the incision are characteristic.
Chronic neuropathic pain in the chest wall, axilla, and medial upper arm after breast cancer surgery — often related to intercostobrachial nerve injury. Produces burning, aching, and phantom breast sensations, frequently with allodynia. Combines neuropathic injury with central sensitization, and is frequently compounded by the emotional weight of breast cancer treatment — an area where ketamine's dual mechanism may be relevant.
Chronic pain following median sternotomy for cardiac surgery — persisting along the sternal incision and chest wall. May involve sternal wire complications, costochondral separation, or intercostal nerve injury, combined with central sensitization. Given the aging cardiac surgery population, post-sternotomy pain is a meaningful contributor to chronic post-surgical pain — particularly relevant to older adults and veterans.
Chronic pain following abdominal surgery — particularly inguinal hernia repair (chronic post-herniorrhaphy pain), where ilioinguinal or genitofemoral nerve entrapment or injury combines with central sensitization. Also occurs after major laparotomy. Produces persistent groin, abdominal wall, or incisional pain with neuropathic features lasting well beyond expected healing.
There is an important distinction between two entirely different uses of ketamine in the surgical context — and understanding it clarifies exactly what Vita Nova does and does not provide.
Ketamine administered intraoperatively by anesthesiologists during surgery may reduce the development of chronic post-surgical pain by blunting the central sensitization at the moment of injury. This is a hospital-based perioperative anesthesia decision made by the surgical anesthesia team — it is not a service Vita Nova provides. Dr. Joshi's perioperative expertise informs the clinical understanding here, but this prevention role happens in the operating room, not at our clinic.
When pain persists beyond the normal healing period — conventionally 3 months — after other causes have been excluded, chronic post-surgical pain is considered established. The central sensitization has become self-sustaining. This is the point at which ketamine evaluation for the chronic syndrome becomes relevant.
Once chronic post-surgical pain has developed and persisted beyond healing, Vita Nova evaluates ketamine infusion therapy for the established central sensitization maintaining the pain. This is the chronic pain syndrome — decoupled from the healed surgical site — that our infusion protocols target. This is our role: the established chronic condition, not the prevention.
To be clear: Vita Nova does not provide perioperative ketamine during surgery, and this page does not suggest ketamine at the time of surgery. We evaluate patients whose chronic post-surgical pain has already become established — typically 3+ months after their procedure — for the treatment of that persistent central sensitization.
Randomized, double-blind, placebo-controlled trial of IV ketamine in patients with phantom limb pain. Ketamine produced significant reductions in phantom limb pain compared with placebo. Because the amputated limb provides no peripheral pain generator, this trial provides especially clean evidence that ketamine acts on the central mechanism maintaining the pain — the strongest mechanistic and controlled-trial case on this page.
Cochrane systematic review examining perioperative ketamine for preventing chronic post-surgical pain. Found that perioperative IV ketamine reduced the incidence of chronic post-surgical pain at 3 and 6 months in several surgical populations. While this addresses prevention (a hospital anesthesia role, not Vita Nova's service), it provides strong evidence that NMDA blockade meaningfully influences the central sensitization process underlying CPSP.
Qualitative systematic review of NMDA antagonists including ketamine in perioperative and chronic pain — establishing that NMDA receptor blockade produces a preventive analgesic effect on central sensitization beyond the drug's direct duration of action. Supported the mechanistic rationale that ketamine acts on the maintained central sensitization underlying persistent post-surgical pain rather than only providing transient analgesia.
The foundational review establishing central sensitization as a distinct pain mechanism driven by NMDA receptor hyperactivity — directly applicable to the transition from acute surgical injury to chronic post-surgical pain. Provided the mechanistic framework explaining why some patients develop persistent pain after surgery and why NMDA-targeted therapy is a rational treatment approach for the established syndrome.
Post-surgical and amputation-related pain carries specific relevance for the veteran and active-duty military community. Combat injuries, traumatic amputations, and the surgical reconstructions that follow place veterans at disproportionately high risk of chronic post-surgical pain and phantom limb pain — often compounded by co-occurring PTSD, which shares the same NMDA-mediated pathways as central sensitization.
Ketamine's dual mechanism — targeting both the central sensitization of chronic post-surgical pain and the mood and trauma dimension through prefrontal synaptogenesis — has particular relevance where amputation-related pain and PTSD co-occur. Treating a documented co-occurring mental health condition alongside the pain may further reduce pain through restored descending inhibition. See our co-occurring depression & chronic pain page and PTSD page.
| Service | Non-Member | Vitality Circle Member | Saving |
|---|---|---|---|
| Ketamine — Chronic Pain / session Off-Label | $1,499.99 | $1,125 | $374.99/session |
If you have a documented co-occurring mental health condition alongside chronic post-surgical pain: treating it may reduce pain through restored descending inhibition — which is why a single evaluation considers your whole pain picture. Particularly relevant for veterans with amputation-related pain and co-occurring PTSD. See our co-occurring depression & chronic pain page.
Self-pay, with a superbill. Every session is anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD — Johns Hopkins faculty and Chief of Thoracic Anesthesia at Johns Hopkins Hospital — in a private treatment room with continuous cardiac and vital-sign monitoring, so the price reflects physician-level, monitored care rather than a walk-in drip. Vita Nova is self-pay for ketamine and provides an itemized superbill you can file with your insurance (see our ketamine insurance guide). HSA and FSA accepted; Community Heroes discounts available. Vitality Circle membership ($99.99/month) pays for itself on a single session — the member rate saves $374.99, more than the membership — and adds a free monthly IV or shots plus 25% off premium IVs. Sessions determined individually — first visit? Read the new patient guide. Pricing August 2026 — subject to change. Full pricing guide →
Magnesium modulates NMDA receptor sensitivity — directly relevant to the central sensitization mechanism of chronic post-surgical pain. Magnesium deficiency increases NMDA excitability, potentially amplifying the maintained sensitization. Surgical patients are frequently magnesium-depleted from perioperative stress, fasting, and recovery demands.
Surgical recovery places significant demands on cellular energy production and tissue repair. NAD+ supports mitochondrial function and cellular energy essential to tissue healing and nerve recovery. Relevant for patients recovering from major surgery whose energy reserves and repair capacity have been depleted by the surgical process and prolonged recovery.
Vitamin C is essential for collagen synthesis and wound healing — directly relevant to surgical recovery. High-dose IV Vitamin C supports tissue repair and addresses the oxidative stress and inflammation of the post-surgical period. Also has documented relevance to preventing CRPS in surgical and trauma contexts (Zollinger et al., 2007), relevant to post-surgical extremity pain.
Major surgery — particularly cardiac, orthopedic, and abdominal procedures — frequently causes significant blood loss and post-surgical iron-deficiency anemia. When bloodwork confirms iron deficiency, IV iron restores stores faster than oral iron and helps address the fatigue and reduced exercise tolerance that slow post-surgical recovery. Iron does not treat the pain itself, but correcting a confirmed deficiency supports the energy needed for rehabilitation.
Clinical note: These wellness services are not treatments for chronic post-surgical pain and are not part of Vita Nova's ketamine protocols. Always discuss supplemental therapy with your surgeon or prescribing physician — particularly during the active post-surgical recovery period.
Real, high-intent questions from patients with chronic post-surgical pain evaluating ketamine and IV therapy in Baltimore.
Full surgical and pain history reviewed. Pain persisting 3+ months post-op evaluated. No commitment.
Book Consultation → View Self-Pay PricingNo commitment · Free insurance verification in 1–2 business days
External links open in a new tab. Vita Nova is not affiliated with these organizations.
Chronic post-surgical pain is not surgical failure — it is central sensitization that persisted after the tissue healed. Ketamine's NMDA mechanism targets that maintained amplification, not the healed surgical site. Phantom limb pain has RCT evidence. Off-label, self-pay with an itemized superbill you can file with your insurance. Community Heroes discounts available.
📍 513 Bayview Blvd · Canton, Baltimore MD 21224 · 🅿️ Free Parking
Mon–Fri: 1PM–8PM · Sat: 10AM–2PM · (443) 563-1059
Medically reviewed by Dr. Brijen L. Joshi, MD — Founder & Medical Director, Johns Hopkins Assistant Professor of Anesthesiology & Critical Care Medicine.
Canonical URL: https://vitanovawellnessclinic.com/ketamine-post-surgical-pain-baltimore/ · Last reviewed August 2026
Baltimore's physician-led clinic for Ketamine, IV vitamin infusions, Iron IV, and NAD+ therapy — serving our community with integrity and care.

Providing compliant, physician-led ketamine & IV therapy care — one of the few clinics certified in Maryland.
See Our Certification →Founded & directed by Dr. Brijen L. Joshi MD, Johns Hopkins School of Medicine faculty.
Meet Dr. Joshi →© 2026 Vita Nova Ketamine & Wellness Clinic. All Rights Reserved.
Disclaimer: All content and advertising on this website are provided for general informational purposes only and do not constitute medical advice, diagnosis, or treatment. Always consult with a licensed healthcare provider regarding your care.
Marketing Statement: No reviews or testimonials on this website have been incentivized, altered, or requested in exchange for compensation. Testimonials reflect individual experiences, and results may vary.
Certification Statement: Vita Nova Ketamine & Wellness Clinic is a REMS-certified treatment center. This website was built with compliance in mind to align with HIPAA, REMS, and LegitScript content requirements.